Metraipolis › archive › dc_407f693b0bfe

Heart failure and tricuspid regurgitation: the role of SGLT2 inhibitors in improving outcomes — Europe PMC PMID:41906747

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41906747
DOI
10.1093/ehjcvp/pvag018
License (as archived)
solo-consultazione
Archived
2026-11-02T21:40:20.652Z
SHA-256 of the archived text
9f47e71bd3dcadd12722c3ac95de1ddf8875fd9fb5aafa17f2ace55d8fc9e73d
Stable URL of this page
https://metraipolis.com/documento/dc_407f693b0bfe

How to cite

Heart failure and tricuspid regurgitation: the role of SGLT2 inhibitors in improving outcomes — Europe PMC PMID:41906747 — Europe PMC (en), https://europepmc.org/article/MED/41906747 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_407f693b0bfe (Metraipolis archive dc_407f693b0bfe, sha256 9f47e71bd3dcadd12722c3ac95de1ddf8875fd9fb5aafa17f2ace55d8fc9e73d)
BibTeX
@misc{dc407f693b0bfe,
  title = {Heart failure and tricuspid regurgitation: the role of SGLT2 inhibitors in improving outcomes — Europe PMC PMID:41906747},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41906747},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_407f693b0bfe; sha256 9f47e71bd3dcadd12722c3ac95de1ddf8875fd9fb5aafa17f2ace55d8fc9e73d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41906747. Agents can read the archived copy with the MCP tool read_document.